Urotensin II in Chronic Kidney Diseases and Kidney Transplants

Vakif Gureba Training and Research Hospital

Status: Completed

Conditions: Chronic Renal Disease

Study type: Observational

Funder types: Other

Identifiers

NCT01098799

Dahiliye-2-Urotensin

Details and patient eligibility

About

The investigators are planning to study the serum level of Urotensin II in chronic kidney disease patients, kidney transplants, and healthy controls.

Full description

The investigators will determine the urotensin II levels in Chronic kidney disease patients, kidney transplants, and healthy controls.

Enrollment: 110 patients

Sex: All

Ages: 18 to 90 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age more than 18

Exclusion criteria

• Inability to give a written consent

Trial design

110 participants in 3 patient groups

Control

Description:

Healthy controls

Chronic kidney disease-1

Description:

Chronic kidney disease not taking dialysis treatment

Kidney Transplant

Description:

Kidney transplants